RFXB and its splice variant RFXBSV mediate the antagonism between IFNγ and TGFβ on COL1A2 transcription in vascular smooth muscle cells

Nucleic Acids Research

Volumn 37, Issue 13, 2009, Pages 4393-4406

  Fang, Mingming ^a,b   Kong, Xiaocen ^a   Li, Ping ^a   Fang, Fei ^a   Wu, Xiaoyan ^a   Bai, Hui ^a   Qi, Xiaohong ^a   Chen, Qi ^a   Xu, Yong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Jiangsu Staff Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1A2; GAMMA INTERFERON; HISTONE DEACETYLASE 2; REGULATORY FACTOR FOR X BOX B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RFXBSV; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; SMOOTH MUSCLE FIBER; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

BINDING, COMPETITIVE; CELLS, CULTURED; COLLAGEN; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HISTONES; HUMANS; INTERFERON-GAMMA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA SPLICING; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 67949121946     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp398     Document Type: Article

References (41)

1. Hansson,G.K. and Libby,P. (2006) The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol., 6, 508-519.
2. Katsuda,S. and Kaji,T. (2003) Atherosclerosis and extracellular matrix. J. Atheroscler. Thromb., 10, 267-274.
3. Libby,P. (2000) Changing concepts of atherogenesis. J. Intern. Med. 247, 349-358.
4. Rekhter,M.D., Zhang,K., Narayanan,A.S., Phan,S., Schork,M.A. and Gordon,D. (1993) Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am. J. Pathol., 143, 1634-1648.
5. Warner,S.J., Friedman,G.B. and Libby,P. (1989) Immune interferon inhibits proliferation and induces 2′-5′-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. J. Clin. Invest., 83, 1174-1182.
6. Frostegard,J., Ulfgren,A.K., Nyberg,P., Hedin,U., Swedenborg,J., Andersson,U. and Hansson,G.K. (1999) Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis, 145, 33-43.
7. Harvey,E.J. and Ramji,D.P. (2005) Interferon-gamma and atherosclerosis: pro- or anti-atherogenic? Cardiovasc. Res., 67, 11-20.
8. Feinberg,M.W. and Jain,M.K. (2005) Role of transforming growth factor-beta1/Smads in regulating vascular inflammation and atherogenesis. Panminerva Med., 47, 169-186.
9. Robertson,A.K., Rudling,M., Zhou,X., Gorelik,L., Flavell,R.A. and Hansson,G.K. (2003) Disruption of TGF-beta signaling in T cells accelerates atherosclerosis. J. Clin. Invest., 112, 1342-1350.
10. Roberts,A.B., Sporn,M.B., Assoian,R.K., Smith,J.M., Roche,N.S., Wakefield,L.M., Heine,U.I., Liotta,L.A., Falanga,V., Kehrl,J.H. et al. (1986) Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. USA, 83, 4167-4171.
11. Rosenbloom,J., Feldman,G., Freundlich,B. and Jimenez,S.A. (1984) Transcriptional control of human diploid fibroblast collagen synthesis by gamma-interferon. Biochem. Biophys. Res. Commun., 123, 365-372.
12. Higashi,K., Inagaki,Y., Fujimori,K., Nakao,A., Kaneko,H. and Nakatsuka,I. (2003) Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem., 278, 43470-43479.
13. Dooley,S., Said,H.M., Gressner,A.M., Floege,J., En-Nia,A. and Mertens,P.R. (2006) Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J. Biol. Chem., 281, 1784-1795.
14. Eickelberg,O., Pansky,A., Koehler,E., Bihl,M., Tamm,M., Hildebrand,P., Perruchoud,A.P., Kashgarian,M. and Roth,M. (2001) Molecular mechanisms of TGF-(beta) antagonism by interferon (gamma) and cyclosporine A in lung fibroblasts. FASEB J., 15, 797-806.
15. Ghosh,A.K., Yuan,W., Mori,Y., Chen,S. and Varga,J. (2001) Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators. J. Biol. Chem., 276, 11041-11048.
16. Tredget,E.E., Wang,R., Shen,Q., Scott,P.G. and Ghahary,A. (2000) Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: Antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J. Interferon Cytokine Res., 20, 143-151.
17. Rishikof,D.C., Ricupero,D.A., Liu,H. and Goldstein,R.H. (2004) Phenylbutyrate decreases type I collagen production in human lung fibroblasts. J. Cell Biochem., 91, 740-748.
18. Guenette,D.K., Ritzenthaler,J.D., Foley,J., Jackson,J.D. and Smith,B.D. (1992) DNA methylation inhibits transcription of procollagen alpha 2(I) promoters. Biochem. J., 283 (Pt 3), 699-703.
19. Xu,Y., Wang,L., Buttice,G., Sengupta,P.K. and Smith,B.D. (2003) Interferon gamma repression of collagen (COL1A2) transcription is mediated by the RFX5 complex. J. Biol. Chem., 278, 49134-49144.
20. Xu,Y., Sengupta,P.K., Seto,E. and Smith,B.D. (2006) Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expression. J. Biol. Chem., 281, 9260-9270.
21. Goldberg,H., Helaakoski,T., Garrett,L.A., Karsenty,G., Pellegrino,A., Lozano,G., Maity,S. and de Crombrugghe,B. (1992) Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells. J. Biol. Chem., 267, 19622-19630.
22. Zhu,X.S. and Ting,J.P. (2001) A 36-amino-acid region of CIITA is an effective inhibitor of CBP: Novel mechanism of gamma interferon-mediated suppression of collagen alpha(2)(I) and other promoters. Mol. Cell Biol., 21, 7078-7088.
23. Sengupta,P., Xu,Y., Wang,L., Widom,R. and Smith,B.D. (2005) Collagen alpha1(I) gene (COL1A1) is repressed by RFX family. J. Biol. Chem. 280, 21004-21014.
24. Zhu,X.S., Linhoff,M.W., Li,G., Chin,K.C., Maity,S.N. and Ting,J.P. (2000) Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell Biol., 20, 6051-6061.
25. Tsai,S.C. and Seto,E. (2002) Regulation of histone deacetylase 2 by protein kinase CK2. J. Biol. Chem., 277, 31826-31833.
26. Nagarajan,U.M., Louis-Plence,P., DeSandro,A., Nilsen,R., Bushey,A. and Boss,J.M. (1999) RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity, 10, 153-162.
27. Xu,Y., Wang,L., Buttice,G., Sengupta,P.K. and Smith,B.D. (2004) Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma). J. Biol. Chem., 279, 41319-41332.
28. Sengupta,P.K., Fargo,J. and Smith,B.D. (2002) The RFX family interacts at the collagen (COL1A2) start site and represses transcription. J. Biol. Chem., 277, 24926-24937.
29. Sobral,L.M., Montan,P.F., Martelli-Junior,H., Graner,E. and Coletta,R.D. (2007) Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures. J. Clin. Periodontol., 34, 397-406.
30. Gu,L., Zhu,Y.J., Guo,Z.J., Xu,X.X. and Xu,W.B. (2004) Effect of IFN-gamma and dexamethasone on TGF-beta1-induced human fetal lung fibroblast-myofibroblast differentiation. Acta. Pharmacol. Sin., 25, 1479-1488.
31. Das,S., Lin,J.H., Papamatheakis,J., Sykulev,Y. and Tsichlis,P.N. (2002) Differential splicing generates Tvl-1/RFXANK isoforms with different functions. J. Biol. Chem., 277, 45172-45180.
32. Zika,E., Greer,S.F., Zhu,X.S. and Ting,J.P. (2003) Histone deacetylase 1/ mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation. Mol. Cell Biol., 23, 3091-3102.
33. Kook,H., Lepore,J.J., Gitler,A.D., Lu,M.M., Wing-Man Yung,W., Mackay,J., Zhou,R., Ferrari,V., Gruber,P. and Epstein,J.A. (2003) Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop. J. Clin. Invest. 112, 863-871.
34. Velican,C. (1969) Relationship between regional aortic susceptibility to atherosclerosis and macromolecular structural stability. J. Atheroscler. Res., 9, 193-201.
35. Amento,E.P., Ehsani,N., Palmer,H. and Libby,P. (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb, 11, 1223-1230.
36. Hall,L.L., Smith,K.P., Byron,M. and Lawrence,J.B. (2006) Molecular anatomy of a speckle. Anat. Rec. A Discov. Mol. Cell Evol. Biol., 288, 664-675.
37. Misteli,T. (2007) Beyond the sequence: Cellular organization of genome function. Cell, 128, 787-800.
38. Bridoux,F., Badou,A., Saoudi,A., Bernard,I., Druet,E., Pasquier,R., Druet,P. and Pelletier,L. (1997) Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J. Exp. Med., 185 1769-1775.
39. Nandan,D. and Reiner,N.E. (1997) TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action. J. Immunol., 158, 1095-1101.
40. Panek,R.B., Lee,Y.J. and Benveniste,E.N. (1995) TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression. J. Immunol., 154, 610-619.
41. Cunha,S.R., Le Scouarnec,S., Schott,J.J. and Mohler,P.J. (2008) Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease. J. Mol. Cell Cardiol., 45, 724-734.